Cytarabine and Idarubicin or Decitabine in Treating Older Patients With Acute Myeloid Leukemia or High-risk Myelodysplastic Syndrome

Conditions:   Adult Acute Myeloid Leukemia;   Adult Myelodysplastic Syndrome;   Secondary Acute Myeloid Leukemia;   Therapy-Related Acute Myeloid Leukemia Interventions:   Drug: Cytarabine;   Drug: Decitabine;   Drug: Idarubicin;   Other: Laboratory Biomarker Analysis;   Other: Quality-of-Life Assessment;   Other: Questionnaire Administration Sponsors:   University of Nebraska;   National Cancer Institute (NCI) Recruiting - verified July 2017 (Source: ClinicalTrials.gov)

MedWorm Message: Have you tried our new medical search engine? More powerful than before. Log on with your social media account. 100% free.

from ! Medicine by Alexandros G. Sfakianakis via alwin on Inoreader http://ift.tt/2tDJUno
via IFTTT